Ahan Chakraborty

Contributing Author

Recent Articles by Ahan Chakraborty

Jul-09	Is Novo Nordisk Increasing Dosage to Defend Wegovy's Edge in Obesity? VKTX LLY NVO Zacks
Jul-07	Will RXRX's Shift in Pipeline Focus Help Restore Investor Faith? RXRX RLAY SDGR Zacks
Jul-04	Will Novo Nordisk's Rare Disease Bets Reduce GLP-1 Reliance? LLY MRK NVO Zacks
Jul-02	Can RXRX's AI-Based Approach Revolutionize the Drug Discovery Process? RXRX RLAY SDGR Zacks
Jun-27	NVO vs. LLY: Which Obesity Powerhouse is the Stronger Bet Now? VKTX AMGN LLY NVO Zacks
Jun-26	Can LLY's Next-Generation Obesity Pipeline Fuel Further Growth? VKTX LLY NVO Zacks
Jun-24	Can Novo Nordisk Regain Ground After Cutting Ties With Hims & Hers? HIMS VKTX LLY NVO Zacks
Jun-19	What is the Intent Behind Eli Lilly's Recent M&A Deals Spree? VERV LLY NVO SNY Zacks
Jun-18	Can Ozempic, Wegovy Drive Further Growth for NVO in the Obesity Space? VKTX AMGN LLY NVO Zacks
Jun-16	Novo Nordisk Stock Rises 6% in a Week: What Should Investors Do? VKTX AMGN LLY NVO Zacks
May-27	RXRX vs. SDGR: Which AI-Powered Drug Discovery Stock Has More Upside? RXRX SDGR LLY SNY Zacks
May-16	Novo Nordisk Stock Gains 14% in a Month: What Should Investors Do? VKTX AMGN LLY NVO Zacks
May-15	Recursion Pharmaceuticals Plunges 22% in May: How to Play the Stock RXRX SNY Zacks
May-05	5 Drug/Biotech Stocks Likely to Outperform Q1 Earnings Estimates DNLI ACAD RARE PCRX NVO Zacks